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Human dental pulp stem cells (hDPSCs) are characterized by high proliferation rate,
the multi-differentiation ability and, notably, low immunogenicity and immunomodulatory
properties exerted through different mechanisms including Fas/FasL pathway. Despite
their multipotency, hDPSCs require particular conditions to achieve chondrogenic
differentiation. This might be due to the perivascular localization and the expression
of angiogenic marker under standard culture conditions. FasL stimulation was able to
promote the early induction of chondrogenic commitment and to lead the differentiation
at later times. Interestingly, the expression of angiogenic marker was reduced by
FasL stimulation without activating the extrinsic apoptotic pathway in standard culture
conditions. In conclusion, these findings highlight the peculiar embryological origin of
hDPSCs and provide further insights on their biological properties. Therefore, Fas/FasL
pathway not only is involved in determining the immunomodulatory properties, but also
is implicated in supporting the chondrogenic commitment of hDPSCs.
Keywords: hDPSCs, Fas/FasL pathway, chondrogenic differentiation, 3D pellet culture, pericytes
INTRODUCTION
Human dental pulp stem cells (hDPSCs) are located in the perivascular area of the loose connective
tissue enclosed within the pulp chamber. Human DPSCs are characterized by a low-invasive
procedures required for isolation, high proliferation rate, low immunogenicity and the ability to
differentiate into different cell lineages (Gronthos et al., 2002). The multi/pluripotency of hDPSCs
can be attributed to their particular embryological derivation from the neural crest. Particularly,
neural crest cells originate during the formation of neural tube, at the third week of embryo
development, then undergo an epithelial-mesenchymal transition (EMT) and migrate to different
body compartments under the control of several regulatory factors. Following migration, neural
crest cells generate the majority of craniofacial tissues, including tooth, fat, muscle, bone and
cartilage tissues, as well as cranial peripheral ganglia and nerves, among other cell types, such
as melanocytes (Pisciotta et al., 2020). It has been widely demonstrated that hDPSCs are able to
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differentiate toward lineages belonging to all the three germ
layers, as a matter of fact these stem cells can commit to glial
cells and participate in peripheral nerve regeneration (Carnevale
et al., 2018), contribute in restoring urethral sphincter contractile
function (Zordani et al., 2019), reduce fibrosis and ameliorate
muscle trophism in Duchenne Muscular Dystrophy mouse
model (Pisciotta et al., 2015b), besides promoting bone tissue
regeneration in critical size calvarial defects (Pisciotta et al.,
2012). Further evidence of the regenerative potential of hDPSCs
is documented by their capability to promote vascularization in
regenerating tissues in vivo and supported by their expression of
VEGF (Laino et al., 2005).
On the other hand, the ability of hDPSCs to commit into
chondrogenic lineage is debated and controversial. Indeed,
findings from literature demonstrated that hDPSCs show high
variability when induced toward chondrogenic differentiation:
this is likely due to the heterogeneity of dental pulp cells
(Iohara et al., 2006; Zhang et al., 2006) and to high oxygen
levels when differentiating hDPSCs in vitro, that do not reflect
the physiological in vivo oxygen tension required for articular
chondrocyte differentiation (Chen et al., 2015). The only cartilage
portion present in the craniofacial district is represented by
Meckel’s cartilage, hyaline cartilage formed in the mandibular
process of the first branchial arch of vertebrate embryos. From
an embryological point of view, chondrocytes are differentiated
from mesodermal cells in general, whereas cells forming Meckel’s
cartilage, are differentiated from ectodermal mesenchymal cells
of neural crest origin (Amano et al., 2010). Moreover, during
intramembranous ossification cartilage is not present and MSCs
from neural crest differentiate directly into osteoblasts.
Beside their differentiation potential, it has been widely
demonstrated by several studies conducted in vitro and in vivo
that hDPSCs can modulate the immune response through
different mechanisms (Wada et al., 2009; Zhao et al., 2012). To
this regard, it is renown that FasL is expressed in different cell
types residing in “immune-privileged” sites, such as the testis, the
eye and the nervous system (Brunlid et al., 2007). Therefore, it
would be helpful to understand how FasL expression modulates
hDPSCs properties.
Taken together, these properties represent the necessary
criteria to define hDPSCs as a suitable stem cells source for
regenerative medicine.
Several findings in literature have highlighted the prominent
role of Fas/FasL pathway in immunomodulation. Particularly, the
activation of Fas/FasL pathway occurs following the exposure
to inflammatory microenvironment which induces apoptosis
in T cells (Pierdomenico et al., 2005; Zhao et al., 2012;
Riccio et al., 2014). Mechanistically, upon binding of FasL
to its receptor CD95, or Fas receptor, the extrinsic apoptotic
pathway is activated with Pro-Caspase 8 and Fas associated
death domain (FADD) being recruited to form the death
inducing signaling complex (DISC), in which Pro-Caspase
8 undergoes activation. Then, Caspase 8 leaves the DISC,
activates caspase 3/7 and induces apoptosis (Chang et al.,
2002; Carnevale et al., 2017). Alternatively, c-FLIP, a protease-
deficient caspase homolog can interact with FADD and act as
an apoptosis inhibitor (Irmler et al., 1997). Besides its key role
in immune system homeostasis maintenance and prevention
of autoimmunity, increasing evidence showed the involvement
of Fas/FasL signaling in further cellular responses, such as
inflammation, proliferation and regeneration (Chang et al.,
2002). These data were further confirmed by previous findings
demonstrating that hDPSCs do express Fas receptor under
standard culture conditions (Pisciotta et al., 2018).
To this regard, the aim of our study was to investigate
whether and how Fas/FasL pathway can affect the stemness
features of hDPSCs and, particularly, the modulation of their
chondrogenic potential.
MATERIALS AND METHODS
Isolation of STRO-1+/c-Kit+ Human
Dental Pulp Stem Cells and
Immunophenotype Characterization
The study was conducted in accordance with the
recommendations of Comitato Etico Provinciale-Azienda
Ospedaliero-Universitaria di Modena (Modena, Italy), which
provided the approval of the protocol (ref. number 3299/CE;
5 September 2017). Human DPSCs were isolated from third
molars of adult subjects (n = 3; 18–25 years) undergoing routine
dental extraction. All subjects gave written informed consent in
compliance with the Declaration of Helsinki.
Cells were isolated from human dental pulp as previously
described (Bianchi et al., 2017). Briefly, dental pulp was harvested
from the teeth and enzymatic digestion was carried out through
a digestive solution (3 mg/ml type I collagenase plus 4 mg/ml
dispase in α-MEM). Pulp was then filtered onto 100 µm Falcon
Cell Strainers, in order to obtain a cell suspension. Then, cell
suspension was plated in 25 cm2 culture flasks and expanded
in standard culture medium (α-MEM supplemented with 10%
heat inactivated foetal bovine serum (FBS), 2 mM L-glutamine,
100 U/ml penicillin, 100 µg/ml streptomycin; all from Sigma
Aldrich, St. Louis, MO, United States) at 37◦C and 5% CO2.
Following cell expansion, hDPSCs underwent immune-selection
by using MACS R© separation kit, according to manufacturer’
instructions. Two sequential immune-selections were performed
by using mouse IgM anti-STRO-1 and rabbit IgG anti-c-Kit
primary antibodies (Santa Cruz Biotechnology, Dallas, TX,
United States). The following magnetically labeled secondary
antibodies were used: anti-mouse IgM and anti-rabbit IgG
(Miltenyi Biotec, Bergisch Gladbach, Germany). The selection
of a homogeneous hDPSCs population expressing STRO-1 and
c-Kit was then evaluated by immunofluorescence analysis, as
described below.
With the aim to provide a visual representation as to
the location and degree of overlap between two wavelengths
corresponding of STRO-1 and c-Kit, co-localization map
was performed by NIS software as previously described
(Gibellini et al., 2012). Briefly, the two-dimensional scatter plot
diagram of the image was analyzed to evaluate the spatial
colocalization of the signals and the Pearson’s correlation
was calculated. Moreover, areas with the strongest colocalized
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signals, corresponding to pixels for both detectors, were
selected to generate colocalization binary maps. In order
to evaluate the expression of the typical mesenchymal stem
cells (MSCs) markers, immune-selected hDPSCs at passage 1
underwent FACS analysis against CD73, CD90, CD105, CD34,
CD45, HLA-DR, as formerly described by Conserva et al.
(2019). Following trypsin dissociation, cells were resuspended
in culture medium and were stained with the following
fluorochrome-conjugated antibodies (Abs): anti-human-CD73-
PE-CY7, -CD90-FITC, -CD105-APC, -CD45-PE, and -HLA-
DR-PE-CY7 (all from BD Biosciences, Franklin Lakes, NJ,
United States); and -CD34-ECD (Beckman Coulter, Fullerton,
CA, United States). A minimum of 10,000 cells per sample was
acquired and analyzed by using the Attune Acoustic Focusing
Flow Cytometer (Attune NxT, Thermo Fisher, Waltham, MA,
United States). Data were analyzed by FlowJo 9.5.7 (Treestar, Inc.,
Ashland, OR, United States) under MacOS 10.
STRO-1+/c-Kit+ hDPSCs were also analyzed for the
expression of HLA-ABC and HLA-DP-DQ-DR by confocal
immunofluorescence analysis. Cells were fixed with 4%
paraformaldehyde (PFA) in pH 7.4 phosphate buffer saline
(PBS) for 20 min and washed in PBS. After rinsing with PBS,
samples were blocked with 3% BSA in PBS for 30 min at room
temperature and then incubated with FITC-conjugated mouse
anti-HLA ABC and mouse anti-HLA-DP-DQ-DR primary
antibodies (BD Biosciences, Franklin Lakes, NJ, United States),
diluted 1:50 in PBS containing 3% BSA, for 1 h at room
temperature. Then, cells were rinsed thrice with PBS and finally,
nuclei were stained with 1 µg/mL 4,6-diamidino-2-phenylindole
(DAPI) in PBS for 5 min (Bianchi et al., 2017); then, samples
were mounted with anti-fading medium (FluoroMount, Sigma
Aldrich, St. Louis, MO, United States) and were observed by a
Nikon A1 confocal laser scanning microscope. The confocal serial
sections were processed with ImageJ software to obtain three-
dimensional projections, and image rendering was performed
using Adobe Photoshop Software (Carnevale et al., 2018).
PBMCs Isolation and Co-culture With
hDPSCs
Human peripheral blood was collected from healthy donors
who gave written informed consent, according to the guidelines
of the ethics committee. Peripheral blood mononuclear cells
(PBMCs) were isolated by using Histopaque R© (Sigma Aldrich,
St. Louis, MO, United States), according to the manufacturer’
instructions, and re-suspended at a density of 106 cells/ml in
RPMI 1640 medium (GIBCO R© Life Technologies Italy, Monza)
supplemented with 10% FBS, 2 mM glutamine, 100 units/ml
penicillin, and 100 µg/ml streptomycin (all from Sigma-Aldrich,
St. Louis, MO, United States). PBMCs were pre-activated by
adding anti-CD3 and the costimulatory anti-CD28 monoclonal
Abs (1 µg/106 PBMCs; BD Biosciences, Franklin Lakes, NJ,
United States) to culture medium and then used for co-culture
experiments (Carnevale et al., 2017). Briefly, for co-culture
experiments hDPSCs were seeded in 6-well plates at a cell
density of 7,000 cells/cm2 and cultured in RPMI 1640 medium
supplemented with 10% FBS, 2 mM glutamine, 100 units/ml
penicillin and 100 µg/ml streptomycin. Upon hDPSCs adhesion,
after 24 h, pre-activated PBMCs were seeded on hDPSCs at a
5:1 ratio and kept in culture for 48 h. At the end of the direct
co-culture, the floating PBMCs were removed together with the
supernatant and discarded, whereas the attached hDPSCs were
processed according to the subsequent experimental procedures.
hDPSCs and pre-activated PBMCs cultured alone were
used as controls.
hDPSCs-PBMCs Co-culture: Evaluation
of Fas/FasL Pathway
In order to evaluate Fas/FasL pathway in hDPSCs cultured alone
and after co-culture with PBMCs, the expression of Fas, FasL,
Caspase 8 and c-FLIP, was investigated by Western blot analysis.
Particularly, whole cell lysates were obtained as formerly reported
(Pisciotta et al., 2018). Briefly, 30 µg of protein extract per
specimen were quantified by a Bradford Protein Assay (Bio-Rad),
then SDS-polyacrylamide gel electrophoresis and subsequent
protein transfer to nitrocellulose membranes were performed.
The following antibodies were used: rabbit anti-FasL, mouse anti-
Fas, mouse anti-Caspase 8 (Cell Signaling Technology, Trask
Lane Danvers, MA, United States), rabbit anti-c-FLIP (R&D
systems, McKinley Place NE, Minneapolis, MN, United States),
diluted 1:1,000 in Tris-buffered saline (TBS) Tween 20 0.1%,
plus 2% BSA and 3% non-fat milk and incubated overnight
at 4◦C. Membranes were then incubated for 1 h at room
temperature with HRP-conjugated anti-mouse and anti-rabbit
secondary antibodies, diluted 1:2,000 in TBS Tween 20 0.1% plus
2% BSA and 3% non-fat milk.
Membranes were then visualized by using Clarity Western
ECL Substrate (Bio-Rad, Alfred Nobel Drive Hercules, CA,
United States), according to the manufacturer’s instructions.
Anti-actin antibody was used as control of protein loading.
Densitometry of FasL, Pro-Caspase 8 and c-FLIP was carried
out with Fiji ImageJ software. An equal area was selected inside
each band, and the mean of gray levels (in a 0–256 scale) was
calculated. Data were then normalized to values of background
and of control actin band (Pisciotta et al., 2018). Moreover, the
expression of FasL in hDPSCs after co-culture with PBMCs was
further evaluated by immunofluorescence analysis, as described
above. Fas expression was also investigated in hDPSCs cultured
alone, through FACS and immunofluorescence analyses.
Stimulation of hDPSCs With Human FasL
Recombinant Protein and Human FasL
Inhibitor
Prior to perform stimulation of hDPSCs with human FasL
recombinant protein (FasL rc) and human FasL inhibitor (FasL
inb) for experimental purposes, the effects on hDPSCs viability
and the potential toxicity of different concentrations of FasL
rc and FasL inb were evaluated, in order to determine the
experimental doses to mimic the exposure of hDPSCs to pre-
activated PBMCs.
hDPSCs were seeded at 7,000 cells/cm2 in a 96-well plate
in α-MEM plus 10% FBS, 2 mM glutamine, 100 units/ml
penicillin, and 100 µg/ml streptomycin and cultured upon
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sub-confluence. Then, culture medium was supplemented with
different concentrations of FasL rc (0.1, 0.2, 0.5 ng/ml) and with
0.5 ng/ml FasL rc + 500 ng/ml FasL inb. Cells were kept under
stimulation for 24 h. hDPSCs cultured without stimulation were
used as controls.
Subsequently, the viability of hDPSCs after FasL rc
stimulation was determined by using the standard MTT [3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]
assay. Cells were incubated for 3 h with MTT reagent at
37◦C. After incubation, the purple formazan crystals were
dissolved in DMSO, at room temperature, then absorbance was
measured at OD = 590 nm by using a multiwell plate reader
(Thermo Scientific Appliskan, Thermo Fisher Scientific). Besides
this, cell proliferation in hDPSCs exposed to different FasL
rc concentrations was evaluated by Western Blot analysis of
PCNA and densitometry analysis was carried out as described
above. To evaluate the expression levels of CCND, CCNA
and CCNB, hDPSCs from each experimental group were
investigated by real-Time PCR. In particular, cells were
homogenized, and total RNA was extracted and purified
using the PureLink RNA columns (Thermo Fisher Scientific).
cDNA synthesis was performed by using Maxima First Strand
cDNA Synthesis Kit with DNase I treatment (Thermo Fisher
Scientific). Quantitative real-time PCRs were performed
using SYBR Green Master mix (Bio-Rad) on CFX Connect
Real-time PCR instrument (Bio-Rad), with the following
oligonucleotides: hRPLP0 (F: TACACCTTCCCACTTGCTGA,
R: CCATATCCTCGTCCGACTCC) hCCND (F: CATCTACACC
GACAACTCCATC, R: TCTGGCATTTTGGAGAGGAAG), hC
CNA (F: AATGGAACACTTGCTTCTGAAAG, R: CTTCAAGT
AGACTCAGCTCTGC), hCCNB (F: CCTCCCTTTTCAGTCC
GC, R: CTCCTGTGTCAATATTCTCCAAATC). Relative
quantification was calculated from the ratio between the
cycle number (Ct) at which the signal crossed a threshold set
within the logarithmic phase of the given gene and that of the
reference hRPLP0. Mean values of the duplicate results of three
independent experiments for each sample were used as individual
data for 2−11Ct statistical analysis (Zordani et al., 2019).
Expression of von Willebrand Factor
in hDPSCs and in Human Dental Pulp
As well established in literature, hDPSCs reside within dental
pulp in close proximity of vessels, thus allowing to define them as
pericytes (Janebodin et al., 2013). It is well known that pericytes
play a key role in maintaining and regulating endothelial cell
structure. Moreover, pericytes in a synergistic fashion with
endothelial cells may regulate vessel formation and maturation,
during angiogenesis process (Bergers and Song, 2005). In light
of this evidence and previous findings demonstrating the ability
of hDPSCs to support tissue vascularization in vivo (Pisciotta
et al., 2012; Pisciotta et al., 2015b), the expression of a typical
angiogenic marker such as von Willebrand factor was evaluated
in hDPSCs when stimulated with FasL rc. To this purpose,
hDPSCs were seeded at 10,000 cells/cm2 in ultra-low attachment
6-well plates, and cultured in DMEM-F12 containing 2% FBS,
2 mM glutamine, 100 units/ml penicillin, and 100 µg/ml
streptomycin in order to obtain 3D floating spheres, as previously
described by Pisciotta et al. (2018). When hDPSCs spheres
aggregated, 0.5 ng/ml FasL rc and 0.5 ng/ml FasL rc+ 500 ng/ml
FasL inb, respectively, were added to culture medium for 24 h.
Then, culture medium was removed and cells were recovered
and attached to slides by using Cytospin (CytospinTM 4, Thermo
Fisher Scientific, Third Avenue Waltham, MA, United States).
Briefly, hDPSCs spheres were collected and resuspended in
300 µl of culture medium, then centrifuged at 1,500 rpm
for 10 min in CytospinTM 4 to let them adhere to slides.
Subsequently, cells were fixed with 4% PFA in PBS for 20 min
at room temperature, then were permeabilized with Triton 0.1%
in PBS for 7 min and immunofluorescence analysis of von
Willebrand factor (vWf) was carried out by using a rabbit anti-
vWf primary antibody (1:100, Merck Millipore, Burlington, MA,
United States), as described earlier.
Human DPSCs cultured as floating spheres without stimuli
were used as controls.
At the same time, samples of human dental pulp (n = 3)
were obtained from healthy donors, after obtaining written
informed consent, during routine tooth extraction procedures.
After extraction, pulps were washed in PBS and fixed in PFA 4%
in PBS for 1 h at room temperature. Then, PFA was removed, with
the samples being washed in PBS and then processed for paraffin
embedding as described by Carnevale et al. (2018). Paraffin-
embedded dental pulps were sectioned by a Microm (Microm
HM 315) microtome and 6 sections per sample (5 µm thickness)
per experimental condition were cut. Half of the sections
underwent routine hematoxylin and eosin (H&E) staining,
whereas the other sections underwent immunofluorescence and
immunohistochemistry analyses against vWf in order to show the
localization of vWf + cells within human dental pulp.
Evaluation of FasL rc Stimulation on the
Activation of Fas/FasL Pathway
In order to investigate the effects triggered by human FasL rc
on hDPSCs at different concentrations, hDPSCs were processed
for Western Blot analysis, as detailed above. The expression of
FasL, Fas, Caspase 8 (Cell Signaling Technology, Trask Lane
Danvers, MA, United States), c-FLIP (R&D systems, McKinley
Place NE, Minneapolis, MN, United States), FADD (mouse anti-
FADD ab; Santa Cruz Biotechnology, Dallas, TX, United States)
was evaluated in hDPSCs after exposure to 0.1 ng/ml, 0.5 ng/ml
FasL rc and to 0.5 ng/ml FasL rc + 500 ng/ml FasL inb for 24 h.
To this regard, hDPSCs exposed to 1 µM Staurosporine were
used as positive control of apoptosis. Densitometry analysis was
performed as described earlier.
Furthermore, the expression of c-FLIP was also evaluated
in hDPSCs after exposure to FasL rc 0.5 ng/ml and to
FasL rc 0.5 ng/ml + FasL inb 500 ng/ml, respectively, by
immunofluorescence analysis with rabbit anti-c-FLIP ab (Santa
Cruz Biotechnology, Dallas, TX, United States). Immunolabeling
intensity of c-FLIP expression in both experimental groups was
evaluated by pseudocolor analysis: blue to white arrays the colors
in a spectrum with blue assigned to a lower value than white
(Carnevale et al., 2017).
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Chondrogenic Differentiation of hDPSCs
As mentioned before, hDPSCs hold a wide differentiation
potential, although findings in literature report that the ability of
these stem cells to reach chondrogenic commitment is debated
(Iohara et al., 2006; Zhang et al., 2006). To this purpose,
chondrogenic differentiation of STRO-1+ /c-Kit+ hDPSCs was
performed under 3D pellet culture, attempting to mimic the
physiological conditions required for articular chondrocyte
differentiation (Chen et al., 2015). Briefly, hDPSCs were cultured
for 7 and 21 days, respectively, in polypropylene tubes at
a density of 5 × 105 cells/tube in chondrogenic medium
consisting in DMEM-HG supplemented with 5% FBS, 100 nM
dexamethasone and 10 ng/ml TGFβ-3, 10 mM 2P-ascorbic acid
(Sigma Aldrich, St. Louis, MO, United States), 1% v/v sodium
pyruvate (Life Technologies, Carlsbad, CA, United States),
50 mg/ml ITS premix (BD Biosciences, Franklin Lakes, NJ,
United States). To evaluate chondrogenic differentiation, cell
pellets from each experimental group were embedded in
paraffin and 5 µm thick sections were obtained by microtome.
Histological analysis by using Alcian Blue and Masson’s
trichrome staining were performed (Pisciotta et al., 2015b;
Conserva et al., 2019).
Moreover, chondrogenic commitment was also confirmed
by Western Blot analysis of SOX9 (rabbit anti-SOX9 ab; Cell
Signaling Technology, Trask Lane Danvers, MA, United States)
on hDPSCs after 7 and 21 days of induction. Besides, the
expression of Fas, FasL and PCNA was investigated as well
to evaluate how Fas/FasL pathway is modulated during the
induction of chondrogenic differentiation. Densitometry analysis
of SOX9, FasL, Fas and PCNA were carried out as detailed above.
The expression of FasL was further evaluated by
immunofluorescence analysis with a rabbit anti-FasL ab
(Santa Cruz Biotechnology, Dallas, TX, United States) after 7
and 21 days of chondrogenic differentiation. Undifferentiated
hDPSCs were used as controls.
Chondrogenic Differentiation of hDPSCs
With the Addition of FasL rc
In order to further evaluate the role of FasL stimulation on
hDPSCs capability to commit toward chondrogenic lineage, FasL
rc was added to cells differentiated under pellet culture method.
In particular, hDPSCs were seeded in polypropylene tubes at a
density of 5× 105 cells/tube in chondrogenic medium additioned
with 0.5 ng/ml Fas rc and 0.5 ng/ml FasL rc + 500 ng/ml FasL
inb, respectively, for 24 h. Then, the stimuli were removed and
chondrogenic differentiation was carried out for 7 and 21 days.
During the 21 days induction time, FasL stimulation was added
to chondrogenic medium once a week.
The chondrogenic commitment was evaluated on hDPSCs
3D pellets sections (5 µm thickness), formerly processed for
paraffin embedding and microtome cut. Immunofluorescence
analysis of SOX9 (Cell Signaling Technology, Trask Lane
Danvers, MA, United States) was performed after 7 days
of induction and quantification of SOX9+ cells was carried
out by counting the number of positively labeled cells in
6 randomly selected fields of 15,000 µm2 per pellet section
(n = 6 slides per experimental group). Then, after 21 days
of chondrogenic induction, Masson’s trichrome and Alcian
Blue stain were carried out in order to evaluate collagen
deposition and the production of sulphured acid mucins
and GAG, respectively. Values calculated on six slides per
experimental group were expressed as mean % area ± standard
deviation (SD). All these measurements were conducted by
using Fiji ImageJ software. Finally, immunohistochemistry with
DAB against Coll-II (mouse anti-Coll-II; Abcam, Cambridge,
United Kingdom) was performed at 21 days of differentiation to
further analyze the achievement of chondrogenic commitment.
Immunohistochemistry was carried out as previously described
(Zordani et al., 2019). All the antibodies used in the study are
indicated in Table 1.
Statistical Analysis
All the experiments were performed in triplicate. Data were
expressed as mean ± SD. Differences between two experimental
conditions were analyzed by paired, Student’s t-test. Differences
among three or more experimental samples were analyzed by
ANOVA followed by Newman–Keuls post hoc test (GraphPad
Prism Software version 5 Inc., San Diego, CA, United States). In
any case, significance was set at P < 0.05.
RESULTS
Isolation of STRO-1+ /c-Kit+ Human
Dental Pulp Stem Cells and
Immunophenotype Characterization
After isolation and expansion of hDPSCs in vitro, magnetic
immunoselection allowed to obtain a STRO-1+/c-Kit+ hDPSCs
population. The expression of these two surface markers
in the selected stem cell population was confirmed by
confocal immunofluorescence analysis (Figures 1A,B). Almost
all immune-sorted cells were positively labeled against c-Kit and
STRO-1 surface antigens, which were distinctly expressed and
detected, as shown by the lack of overlapping signals revealed
by the colocalization map (Figure 1C). Moreover, immune-
phenotypical characterization through FACS analysis revealed
that all the typical MSCs markers were expressed by STRO-
1+/c-Kit+ hDPSCs, while being CD45/HLA-DR negative and,
only to a lesser extent, CD34 positive (Figure 1D) which is in
accordance with previous findings (Pisciotta et al., 2015a). At
the same time, confocal immunofluorescence analysis showed
the positive labeling against HLA-ABC antigens and the lack of
expression of HLA DP-DQ-DR antigens in the selected hDPSCs
population (Figure 1E).
hDPSCs-PBMCs Co-culture: Evaluation
of Fas/FasL Pathway
After co-culture of hDPSCs and PBMCs for 48 h (Figure 2A),
the expression of FasL, Caspase 8 and c-FLIP was evaluated
by Western Blot analysis in hDPSCs cultured alone and in
hDPSCs after co-culture (Figure 2B). Densitometry analysis
showed a significant increase in FasL expression in hDPSCs after
Frontiers in Cell and Developmental Biology | www.frontiersin.org 5 May 2020 | Volume 8 | Article 279
fcell-08-00279 May 13, 2020 Time: 17:35 # 6
Pisciotta et al. Fas/FasL Promotes hDPSCs Chondrogenic Differentiation
TABLE 1 | List of used antibodies.
Name Host Source Dilution Application
anti-human-CD73-PE-CY7 mouse BD Biosciences 1:50 FACS
anti-human-CD90-FITC mouse BD Biosciences 1:50 FACS
anti-human-CD105-APC mouse BD Biosciences 1:50 FACS
anti-human-CD45-PE mouse BD Biosciences 1:50 FACS
anti-human-HLA-DR-PE-CY7 mouse BD Biosciences 1:50 FACS
anti-human-CD34-ECD mouse Beckman Coulter 1:50 FACS
anti-human-HLA ABC-FITC mouse BD Biosciences 1:50 IF
anti-HLA-DP-DQ-DR-FITC mouse BD Biosciences 1:50 IF
anti−FasL rabbit Cell Signaling Technology 1:1000 WB
anti−FasL rabbit Santa Cruz Biotechnology 1:50 IF
anti-Fas mouse Cell Signaling Technology 1:50 1:1000 FACS WB
anti-Caspase 8 mouse Cell Signaling Technology 1:1000 WB
anti-c-FLIP rabbit R&D systems 1:1000 WB
anti-c-FLIP rabbit Santa Cruz Biotechnology 1:50 IF
anti-vWf rabbit Merck Millipore 1:100 IF
anti-FADD mouse Santa Cruz Biotechnology 1:1000 WB
anti-SOX9 rabbit Cell Signaling Technology 1:1000 WB
anti-Coll-II mouse Abcam 1:50 IHC
co-culture with PBMCs, when compared to hDPSCs cultured
alone (∗P < 0.05 vs hDPSCs alone; Figure 2B). This data
was confirmed by immunofluorescence analysis (Figure 2B).
Contemporarily, Fas expression was detected in hDPSCs after co-
culture with PBMCs, as demonstrated by Western Blot analysis.
Interestingly, no statistically significant difference was shown
when compared to hDPSCs cultured alone, indeed FACS and
immunofluorescence analyses showed that hDPSCs express Fas
yet in standard culture conditions (almost 48% of the cells;
Figure 2C). Western Blot analysis also allowed to evaluate
the expression of Pro-Caspase 8, which revealed an increased
expression in hDPSCs after co-culture (∗P < 0.05 vs hDPSCs
alone; Figure 2D). On the other hand, the antibody did not show
any labeling against cleaved Caspase 8, therefore demonstrating
that activation of the apoptotic cascade did not occur in any
of hDPSCs experimental groups. Western Blot analysis also
showed an increase in c-FLIP expression in hDPSCs after co-
culture, with respect to hDPSCs alone (∗P < 0.05 vs hDPSCs
alone; Figure 2D).
Stimulation of hDPSCs With Fas-L rc and
Fas-L inb: Cell Viability and Proliferation
Following the stimulation with FasL rc and FasL inb, MTT
analysis showed an increase in cell viability at increasing
concentrations of FasL rc, indeed, when the highest concentration
was used (0.5 ng/ml) cell viability was higher than in the
untreated control (Figure 3A). In particular, the untreated
control and hDPSCs treated with the highest concentration
of FasL rc showed a statistically significant higher viability,
compared to hDPSCs treated with the lowest concentration
of FasL rc (0.1 ng/ml) (∗P < 0.05 vs hDPSCs + FasL rc
0.1 ng/ml; Figure 3A). When hDPSCs treated with FasL rc
(0.5 ng/ml) were additioned with FasL inb, MTT values were
almost reverted to control conditions (Figure 3A). Western Blot
analysis of PCNA was also performed on hDPSCs after 24 h
of stimulation (Figure 3B). A statistically significant increase
in PCNA expression was detected in hDPSCs stimulated with
FasL rc 0.5 ng/ml when compared to hDPSCs stimulated with
FasL rc + FasL inb (∗P < 0.05 vs hDPSCs with FasL rc + FasL
inb; Figure 3B). The untreated control showed statistically
significant higher levels of PCNA, with respect to hDPSCs
stimulated with FasL rc 0.1 ng/ml (∗P < 0.05 vs hDPSCs + FasL
rc 0.1 ng/ml; Figure 3B). These data confirmed the results
obtained through MTT assay. Likewise, real-Time PCR analysis
of mRNA expression of CCND, CCNA and CCNB revealed a
statistically significant mRNA fold increase in CCND and CCNB
in hDPSCs treated with FasL rc 0.5 ng/ml, thus confirming
that the stimulation with FasL rc at its highest concentration
triggered a greater proliferation in hDPSCs (∗P< 0.05 vs hDPSCs
ctrl; Figure 3C).
Expression of von Willebrand Factor
in hDPSCs and in Human Dental Pulp
As highlighted in Figure 3D, pericytes can be recognized
within human dental pulp close to vessels, by their cell
morphology, as shown by H&E stain (black arrows; Figure 3D).
Immunofluorescence and immunohistochemistry analyses
confirmed the localization in vivo of vWf+ dental pulp
cells adjacent to blood vessels (yellow square and arrows;
black arrows; Figure 3D). Immunofluorescence analysis
performed on hDPSCs cultured as 3D floating spheres
confirmed that cells express the angiogenic marker von
Willebrand factor, when cultured under standard expansion
conditions. On the contrary, hDPSCs lost the expression of
vWf after stimulation with FasL rc at its highest concentration
(0.5 ng/ml; Figure 3E).
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FIGURE 1 | Mesenchymal profile of immune-selected hDPSCs. (A) Immunofluorescence analysis on hDPSCs after immune-selection with MACS shows the
expression of stemness markers c-Kit (green) and STRO-1 (red). DIC image shows the morphological phenotype of hDPSCs. Nuclei are counterstained with DAPI.
Bar = 10 µm. (B) Three dimensional reconstruction of optical sections acquired for each fluorescent signal. (C) Co-localization binary map of STRO-1 and c-Kit
signals is shown. On the right, representative dot plots of co-localization signals are reported. (D) Fluorescence-activated cell sorting (FACS) analysis performed on
immune-selected hDPSCs. (E) Expression of major histocompatibility complex class I (HLA ABC) and class II (HLA DP DQ DR). Bar = 10 µm.
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FIGURE 2 | Evaluation of Fas/FasL pathway on both hDPSCs cultured alone and after co-culture with PBMCs. (A) Phase contrast image of hDPSCs cultured with
PBMCs. (B) Western Blot analysis of FasL in both hDPSCs cultured alone and after co-culture with PBMCs. Histograms represent the mean ± SD (n = 3) of
densitometry of FasL, *P < 0.05 hDPSCs after PBMCs co-culture vs hDPSCs cultured alone. The expression of FasL after co-culture with PBMCs was confirmed by
confocal immunofluorescence analysis. Nuclei are counterstained with DAPI. Bar = 10 µm. (C) Western Blot analysis of Fas (CD95) in both hDPSCs cultured alone
and after co-culture with PBMCs. FACS analysis confirms the positive expression of Fas in hDPSCs cultured alone. The expression of Fas on live hDPSCs cultured
alone was also evaluated by Immunofluorescence analysis. DIC Image shows the morphological phenotype of hDPSCs. (D) Western blot analysis of pro-caspase 8,
cleaved caspase 8 and c-FLIP performed on hDPSCs cultured alone and after co-culture with PBMCs. Actin bands were presented as control of protein loading;
histograms represent mean ± SD, *P < 0.05 hDPSCs after PBMCs co-culture vs hDPSCs cultured alone.
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FIGURE 3 | Stimulation of hDPSCs with human recombinant FasL. (A) MTT assay was performed on hDPSCs after stimulation with different concentrations of FasL
rc. (B) Western blot analysis of PCNA in hDPSCs stimulated with FasL rc. Histograms represent the mean ± SD (n = 3) of densitometry of PCNA; *P < 0.05
hDPSCs ctrl and hDPSCs treated with FasL rc 0.5 ng/ml vs hDPSCs treated with FasL rc 0.1 ng/ml. (C) Real–time PCR analysis showing fold increase of mRNA
levels of CCND, CCNA and CCNB in hDPSCs following stimulation with FasL rc. Data represent mean ± SD of fold change obtained from five independent
experiments; *P < 0.05 hDPSCs treated with FasL rc 0.5 ng/ml vs hDPSCs treated with FasL rc 0.1 ng/ml. FasL inhibitor was used for FasL rc blocking.
(D) Representative image of histological section of human dental pulp stained with H&E, magnification 10×. Black arrows indicate the pericytes close to vessels.
Immunofluorescence analysis of vWf was performed on paraffin-embedded section of dental pulp. Yellow square indicates the area of high magnification (right side).
Yellow arrows highlight vWf positive pericytes. On the right, immunohistochemistry analysis of vWf with black arrows indicating the presence of vWf+ cells close to
vessels, magnification 20×. Bar = 50 µm. (E) Immunofluorescence analysis of vWf was carried out on hDPSCs 3D spheres after treatment with FasL rc 0.5 ng/ml.
hDPSCs 3D spheres untreated were used as control. Bar = 10 µm.
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Stimulation of hDPSCs With FasL rc and
FasL inb: Evaluation of Fas/FasL
Pathway
Following stimulation with FasL rc and FasL inb, Western Blot
analyses were carried out to investigate the expression of different
proteins related to the Fas/FasL pathway, such as FasL, Fas,
FADD, c-FLIP, Pro-Caspase 8 and cleaved Caspase 8 (Figure 4A).
As shown by densitometry analyses, there was a statistically
significant increase in FasL expression in stimulated hDPSCs
compared to untreated control (∗P < 0.05 vs hDPSCs ctrl).
As far as Fas receptor is concerned, a significant
downregulation was observed in hDPSCs stimulated with
0.5 ng/ml FasL rc, compared to the untreated control exhibiting
basal levels of Fas (∗P < 0.05 vs hDPSCs ctrl). Similarly, a
statistically significant decrease in Fas expression was observed
in hDPSCs stimulated with 0.1 ng/ml FasL rc (∗P < 0.05 vs
hDPSCs ctrl). On the other hand, a slight – although statistically
not significant – decrease in Fas expression was revealed in
hDPSCs treated with FasL rc + FasL inb, showing values similar
to control cells. The expression of FADD was not affected by
stimulation, indeed a slight decrease was noticed only when
hDPSCs were treated with FasL rc + FasL inb (∗P < 0.05 vs
hDPSCs ctrl). Conversely, a statistically significant augmentation
of c-FLIP expression was demonstrated in hDPSCs following
stimulation with 0.5 ng/ml FasL rc and the treatment with FasL
rc + FasL inb, respectively (∗∗P < 0.01, ∗P < 0.05 vs hDPSCs
ctrl). As shown by Western Blot analysis, there was no activation
of the apoptotic pathway, as cleaved Caspase 8 was not expressed
(Figure 4A). Subsequently, confocal immunofluorescence
analysis also confirmed the increase in c-FLIP expression in
hDPSCs treated with 0.5 ng/ml FasL rc, when compared to
unstimulated control (Figure 4B). The pseudocolor analysis
highlighted a higher intensity in c-FLIP immunolabeling in
hDPSCs stimulated with FasL rc compared to hDPSCs treated
with FasL rc+ FasL inb (Figure 4B).
Evaluation of Chondrogenic
Differentiation of hDPSCs in vitro
After in vitro expansion, the ability of STRO-1+/c-Kit+ hDPSCs
to differentiate toward the chondrogenic lineage was evaluated.
After 7 and 21 days of induction to chondrogenic differentiation,
the commitment of hDPSCs, cultured as 3D cell pellets, was
investigated through histochemical staining with Alcian Blue
and Masson’s trichrome stain. In particular, Alcian blue staining
demonstrated the presence of sulphured acid mucins and
glycosaminoglycans (GAG) containing carboxylic groups, at 7
and 21 days of induction (Figure 5A). Masson’s trichrome
staining highlighted the presence of collagen (blue) after 7 and
21 days of chondrogenic differentiation of hDPSCs. In particular,
an increased amount of collagen deposition was revealed after
21 days of induction, with respect to the earlier time of induction
(Figure 5B). After 7 and 21 days of culture in chondrogenic
medium, the commitment was also evaluated by Western Blot
analysis (Figure 5C). In particular, the expression of SOX9,
a typical marker of early chondrogenic differentiation, was
statistically significant increased after 7 days of induction, while
statistically significant decreasing after 21 days of induction,
when compared to undifferentiated control (§§P < 0.01 hDPSCs
diff 7-day vs hDPSCs undiff; ∗∗P < 0.01 hDPSCs diff 21-
day vs hDPSCs undiff). Besides, the expression of SOX9 after
21 days of induction was statistically significant lower, when
compared to the undifferentiated control and to hDPSCs after
7 days of induction, respectively (∗∗P < 0.01 vs hDPSCs undiff;
∗∗∗P < 0.001 vs hDPSCs diff 7-day). Western blot analysis also
evaluated the expression of other proteins, such as FasL, Fas
and PCNA. The expression of FasL was statistically significant
increased after 7 and 21 days of induction (∗∗P < 0.01 hDPSCs
diff 7-day vs hDPSCs undiff, ∗P < 0.05 hDPSCs diff 21-day
vs hDPSCs undiff), while PCNA expression was statistically
significant lower at 7 and 21 days of induction, compared
to undifferentiated control (∗∗P < 0.01 vs hDPSCs diff 7-day
and hDPSCs diff 21-day). Fas expression showed a statistically
significant increase in hDPSCs at 7 days of induction, when
compared to undifferentiated hDPSCs and to hDPSCs at 21 days
of induction, respectively (∗P< 0.05 vs hDPSCs undiff, ∗P< 0.05
vs hDPSCs diff 21-day; Figure 5C). FasL expression was also
confirmed by confocal immunofluorescence analysis performed
on hDPSCs 3D pellet sections at different times of chondrogenic
commitment. The data are in agreement with Western Blot
analysis, in fact, the expression of FasL showed an increase after 7
and 21 days of induction to differentiation (Figure 5D).
Role of FasL Stimulation in
Chondrogenic Induction of hDPSCs
The induction to chondrogenic differentiation of hDPSCs with
the addition of FasL rc and FasL rc + FasL inb was evaluated
by confocal immunofluorescence, Masson’s trichrome, Alcian
Blue stain and immunohistochemistry analyses. As reported
in Figure 6A, SOX9 showed a differential expression among
the three experimental groups after 7 days of chondrogenic
induction. In particular, as shown in Figure 6B, hDPSCs
3D pellets stimulated with FasL rc 0.5 ng/ml after 7 days
of differentiation, revealed a statistically significant higher
number of SOX9+ cells when compared to hDPSCs 3D pellet
differentiated without FasL rc stimulation and to hDPSCs 3D
pellet differentiated plus FasL rc 0.5 ng/ml and FasL inb 500
ng/ml, respectively (∗∗∗P < 0.001 vs hDPSCs diff; §§§P < 0.001
vs hDPSCs + FasL rc 0.5 ng/ml + FasL inb 500 ng/ml). These
data suggest that the stimulation of hDPSCs 3D pellets with FasL
rc + FasL inb triggered a reduction in SOX9 expressing cells
to levels resembling hDPSCs diff. As far as later differentiation
time is concerned, Masson’s trichrome and Alcian Blue stain
highlighted that collagen deposition and sulphured acid mucins
and GAG production were greater in hDPSCs differentiated
plus the addition of FasL rc stimulation (Figure 6C). As
shown in Figure 6D, Masson’s trichrome and Alcian Blue stain
quantifications revealed that hDPSCs differentiated plus FasL
rc stimulation reached the chondrogenic differentiation to a
greater extent, when compared to hDPSCs differentiated without
FasL rc stimulation (∗∗∗P < 0.001 vs hDPSCs diff). When
both FasL rc and FasL inb were added, hDPSCs still showed
a greater induction with respect to hDPSCs diff (∗P < 0.05),
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FIGURE 4 | Evaluation of Fas/FasL pathway in hDPSCs following stimulation with FasL rc. (A) Western Blot analysis of FasL, Fas, FADD, c-FLIP, pro-caspase 8 and
cleaved caspase 8 in hDPSCs after stimulation with FasL rc at different concentrations. hDPSCs treated with 1 µM Staurosporine were used as positive control of
cleaved caspase 8. At the bottom, histograms represent mean ± SD (n = 3) of densitometry of FasL, Fas, FADD and c-FLIP; *P < 0.05 and **P < 0.01 vs hDPSCs
ctrl. (B) Confocal immunofluorescence analysis of c-FLIP was performed in hDPSCs stimulated with FasL rc 0.5 ng/ml and with FasL rc 0.5 ng/ml + FasL inb
500 ng/ml. On the right of each immunofluorescent image is reported pseudocolor analysis of c-FLIP staining intensity. Bar = 10 µm.
although resulting in a statistically significant lower induction,
when compared with hDPSCs differentiated plus FasL rc
stimulation (§§P < 0.01 vs hDPSCs diff + FasL rc 0.5 ng/ml).
Immunohistochemistry analysis of Coll-II further showed that
matrix deposition was notably higher in hDPSCs differentiated
plus FasL rc stimulation, when compared to hDPSCs diff and
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FIGURE 5 | Chondrogenic differentiation of hDPSCs. (A) Evaluation of chondrogenic commitment of hDPSCs at 7 and 21 days of induction. Cell pellet sections
were stained by Alcian Blue, magnification 10×. Bar = 50 µm. (B) Masson’s trichrome staining was carried out to analyze the collagen deposition (blue) in hDPSCs
at different time points. Black squares highlight areas of higher magnification on the right side of each image. Bar = 50 µm. (C) Western Blot analysis showing
expression of SOX9, FasL, Fas and PCNA through the chondrogenic induction of hDPSCs. Histograms represent mean ± SD (n = 3) of densitometry of SOX9, FasL,
PCNA and Fas. With regard to SOX9: **P < 0.01 hDPSCs undiff vs hDPSCs diff 21-day, ***P < 0.001 hDPSCs 7-day vs hDPSCs diff 21-day; §§P < 0.01 hDPSCs
diff 7-day vs hDPSCs undiff; with regard to FasL: *P < 0.05 hDPSCs diff 21-day vs hDPSCs undiff; **P < 0.01 hDPSCs diff 7-day vs hDPSCs undiff; with regard to
PCNA: **P < 0.01 hDPSCs undiff vs hDPSCs diff 7-day and **P < 0.01 hDPSCs undiff vs hDPSCs diff 21-day; with regard to Fas: *P < 0.05 hDPSCs diff 7-day vs
hDPSCs undiff and *P < 0.05 hDPSCs diff 7-day vs hDPSCs diff 21-day. (D) Immunofluorescence images showing FasL expression at different times of
commitment. Bar = 20 µm.
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FIGURE 6 | Effects of FasL stimulation on chondrogenic differentiation of hDPSCs. (A) Expression of early chondrogenic marker SOX9 was assayed in hDPSCs by
confocal immunofluorescence analysis at 7 days of chondrogenic induction supplemented with FasL rc 0.5 ng/ml and with FasL rc 0.5 ng/ml + FasL inb 500 ng/ml,
respectively. hDPSCs differentiated without adding FasL stimulation were used as controls (hDPSCs diff). Red squares show nuclei stained with DAPI. Bar = 20 µm.
(B) Histograms representing the mean percentage of SOX9+ cells/15,000 µm2 area ± SD. ***P < 0.001 vs hDPSCs diff; §§§P < 0.001 vs hDPSCs diff + FasL rc
0.5 ng/ml + FasL inb 500 ng/ml. (C) Representative images of Masson’s trichrome and Alcian Blue stained sections from hDPSCs 3D pellet show collagen
deposition and the presence of acid mucins and GAG among the three different experimental groups. Black squares indicate areas of higher magnification, reported
on the right side. Bar = 50 µm. (D) Histograms showing percentage areas of collagen deposition and Alcian Blue stain of 3D pellet sections from each experimental
group (n = 6). Data are expressed as mean ± SD. *P < 0.05, ***P < 0.001 vs hDPSCs diff; §§P < 0.01 vs hDPSCs + FasL rc 0.5 ng/ml + FasL inb 500 ng/ml.
(E) Immunohistochemistry images showing the expression of late chondrogenic marker Coll-II in differentiated hDPSCs exposed to FasL rc 0.5 ng/ml and FasL rc
0.5 ng/ml + FasL inb 500 ng/ml. hDPSCs differentiated without adding FasL stimulation (hDPSCs diff), were used as controls. Black squares indicate areas of higher
magnification, reported on the right side, magnification 10×. Bar = 50 µm.
hDPSCs diff + FasL rc + FasL inb, confirming the achievement
of chondrogenic commitment (Figure 6E).
DISCUSSION
Human dental pulp stem cells (hDPSCs) represent a
heterogeneous cell population enclosed in the loose connective
tissue. The immune-selection against the stemness markers
c-Kit and STRO-1 allows to obtain a purer stem cell niche
with a typical mesenchymal phenotype. It has been widely
demonstrated that c-Kit+/STRO-1+ hDPSCs are able to
differentiate in vitro toward all the three germ layer derived
lineages (Laino et al., 2005; Carnevale et al., 2013) due to
their peculiar embryological origin from the neural crest.
The multipotency of hDPSCs has been further confirmed
by several findings reporting their regeneration potential
when applied to different animal models of tissue injuries. In
particular, when hDPSCs were studied for the regeneration
of bone, muscle and peripheral nerve tissues, not only
they committed toward the host tissue cells but also they
promoted the tissue healing by triggering angiogenesis
(D’Aquino et al., 2007; Pisciotta et al., 2015b; Zordani
et al., 2019). To this regard, it is noteworthy that hDPSCs
can be localized within dental pulp in the perivascular
area, thus being defined as pericytes (Janebodin et al.,
2013). Although it has been demonstrated that hDPSCs are
able to commit toward the mesenchyme related lineages,
the chondrogenic differentiation ability of hDPSCs is
still controversial.
It is well known that from an embryological point of
view, neural crest derived cells contribute to the formation
of the craniofacial district tissues. During the embryological
development the poorly represented chondrogenic tissue is
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immediately replaced by newly synthesized bone tissue supported
by neo-angiogenesis. The only portion of cartilage tissue is
represented by Meckel’s cartilage. This hyaline cartilage, formed
in the mandibular process of the first branchial arch of vertebrate
embryos, is not involved in bone formation although supporting
the intramembranous ossification (Amano et al., 2010). Based on
these considerations it can be argued that neural crest derived
stem cells require particular conditions to differentiate toward
chondrogenic tissue.
In order to understand chondrogenic potential of hDPSCs,
3D culture pellet mimicking the physiological conditions
of chondrocytes differentiation was performed. Data from
the early phase of chondrogenic induction revealed high
levels of FasL suggesting that it may exert a key role in
promoting the early induction of chondrogenic commitment,
besides being expressed along the whole differentiation time.
Therefore, it may be assumed that Fas/FasL pathway is not
only involved in the immunomodulation (Zhao et al., 2012;
Riccio et al., 2014; Carnevale et al., 2017). To investigate
how Fas/FasL pathway affects hDPSCs biological properties,
stem cells expressing high levels of Fas were stimulated with
different concentrations of human recombinant FasL protein.
This stimulation aimed to mimic the effects of the exposure
to inflammatory microenvironment and revealed that, not
only undifferentiated hDPSCs avoided apoptosis, but were still
proliferating. These findings are in accordance with a previous
report showing that Fas, a classically pro-apoptotic molecule, is
also able to promote increased cell proliferation in different types
of cells including hepatocytes (Budd, 2002). Further studies also
demonstrated that high levels expression of c-FLIP counteract
the signals of cell death toward a growth signal pathway
(Ashany et al., 1999).
Interestingly, at early times of differentiation, an increase in
SOX9+ hDPSCs was evident, thus suggesting a pro-inductive
effect of FasL toward chondrogenic commitment. At later times
of differentiation, an augmentation in Coll-II deposition was
revealed, demonstrating how FasL is able to play a conductive
role by leading the chondrogenic commitment of hDPSCs. These
findings confirm previous evidence reporting that FasL expressed
by mature chondrocytes exerts a cytoprotective effect (Ryu et al.,
2012). At the same time, FasL plays an inhibitory role in the
promotion of angiogenesis by inducing Fas mediated apoptosis
of vascular endothelial cells, and consequently might avoid the
cartilage replacement with bone tissue (Sun et al., 2013). Indeed,
as reported the FasL stimulation, added to culture medium, was
able to decrease the expression of angiogenic marker and favor
more suitable microenvironment for chondrogenic induction.
In conclusion, we can affirm that Fas/FasL pathway (1) not
only confers hDPSCs the ability to avoid apoptosis induction
when exposed to immune cells but also is primary for the
maintenance of proliferation properties of hDPSCs, and (2)
is inductive and conductive of chondrogenic commitment by
inhibiting the expression of angiogenic marker of neural crest
derived pericytes.
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